Not a doctor, just a colon cancer survivor, so from my experience, oncologists use CT (and other) scans and a CEA (blood) test to monitor effectiveness of the chemotherapy. There is also a blood test called Signatera (I've not had that one.)
To simplify, the scans show if tumors are growing/shrinking (the therapy is not working/is working), the CEA/Signatera indicates the activity (aggressiveness) of the cancer.
My understanding, which could be wrong, is that oncologists want you to complete a full course of treatment (when your body can handle it) then reevaluate if another therapy or doing another course of treatment is necessary.
Stopping in the middle of a course seems unusual unless there are problems tolerating it, it is found to be ineffective or the cancer has spread elsewhere.
Let's see what others have to say.
What do you think of this study? ncbi.nlm.nlh.gov